QRSL1 and cancer: Looking ahead, several promising research avenues should be explored to deepen our understanding of the intricate regulatory crosstalk between ncRNAs and GATA transcription factors in cancer and their potential roles of the ncRNA-GATA axis in tumor heterogeneity and immunotherapy.